Baseline lipoprotein

3 papers mention it1 finding

Associations

1

Longitudinal increase in lipoprotein

upin humans1

1 study

Baseline lipoprotein is associated with longitudinal increase in lipoprotein in humans (ρ 0.37–0.63, all p < 0.05).
“higher levels associated with greater increases at all timepoints (ρ 0.37-0.63, all p < 0.05)”
Humansamong individuals with increases in lipoprotein(a) following acute coronary syndrome
Temporal changes in lipoprotein(a) after acute coronary syndrome
American journal of preventive cardiologyAug 28, 2026

More on Longitudinal increase in lipoprotein

Latest

3 papers in 12 months

AtherosclerosisSep 30

Lipoprotein(a) reduction with PCSK9-targeting pharmacotherapy: A prospective real-world registry study

Cohort study of 1,112 peopleInterventions

LancetAug 28

Safety and lipoprotein(a)-lowering effects of Kylo-11, a non-canonical, long-duration small interfering RNA targeting lipoprotein(a): a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial

Randomized trial in 70 peopleInterventions

Journal of Clinical MedicineAug 13

Bempedoic Acid in Patients with Chronic Coronary Syndrome Not Achieving LDL Targets Despite Intensive Therapy: A Real-World Study from Spain

Cohort study of 118 peopleBempedoic acid